Monte Rosa Therapeutics, Inc. (GLUE)
13.78
-0.52
(-3.67%)
USD |
NASDAQ |
Aug 24, 16:00
13.77
0.00 (0.00%)
After-Hours: 20:00
Monte Rosa Therapeutics Market Cap : 1.174B for Aug. 24, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Market Cap Data
| Date | Value |
|---|---|
| August 24, 2026 | 1.174B |
| August 21, 2026 | 1.219B |
| August 20, 2026 | 1.260B |
| August 19, 2026 | 1.344B |
| August 18, 2026 | 1.281B |
| August 17, 2026 | 1.311B |
| August 14, 2026 | 1.321B |
| August 13, 2026 | 1.350B |
| August 12, 2026 | 1.359B |
| August 11, 2026 | 1.343B |
| August 10, 2026 | 1.348B |
| August 07, 2026 | 1.353B |
| August 06, 2026 | 1.339B |
| August 05, 2026 | 1.330B |
| August 04, 2026 | 1.370B |
| August 03, 2026 | 1.297B |
| July 31, 2026 | 1.393B |
| July 30, 2026 | 1.912B |
| July 29, 2026 | 1.818B |
| July 28, 2026 | 1.858B |
| July 27, 2026 | 1.902B |
| July 24, 2026 | 1.921B |
| July 23, 2026 | 1.942B |
| July 22, 2026 | 2.006B |
| July 21, 2026 | 1.993B |
| Date | Value |
|---|---|
| July 20, 2026 | 1.980B |
| July 17, 2026 | 2.071B |
| July 16, 2026 | 1.953B |
| July 15, 2026 | 1.974B |
| July 14, 2026 | 1.978B |
| July 13, 2026 | 1.853B |
| July 10, 2026 | 1.943B |
| July 09, 2026 | 2.068B |
| July 08, 2026 | 2.029B |
| July 07, 2026 | 2.057B |
| July 06, 2026 | 1.960B |
| July 02, 2026 | 2.041B |
| July 01, 2026 | 2.025B |
| June 30, 2026 | 2.041B |
| June 29, 2026 | 2.015B |
| June 26, 2026 | 1.880B |
| June 25, 2026 | 1.826B |
| June 24, 2026 | 1.758B |
| June 23, 2026 | 1.746B |
| June 22, 2026 | 1.574B |
| June 18, 2026 | 1.544B |
| June 17, 2026 | 1.552B |
| June 16, 2026 | 1.498B |
| June 15, 2026 | 1.528B |
| June 12, 2026 | 1.538B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Nurix Therapeutics, Inc. | 2.724B |
| Gilead Sciences, Inc. | 182.10B |
| Ironwood Pharmaceuticals, Inc. | 682.44M |
| Capricor Therapeutics, Inc. | 395.14M |
| Cue Biopharma, Inc. | 121.22M |
Market Cap Related Metrics
| PS Ratio | 41.87 |
| Price to Book Value | 2.409 |
| Price | 13.78 |
| Earnings Yield | -13.84% |